The FDA approves gel against bloodshed

After bloodshed can cause death within minutes on the battlefield, the first aid that could stop the bloodshed could save lives.

TraumaGel, an advanced product of first aid, developed by the US biotechnology brand, “Cresion Inc.”, has been approved by the US Food and Barna Administration, writes “I-hls”.

This product is used to stop the bleeding caused by injuries. It is designed to apply directly to the wound to help stop the bleeding and can be used by both doctors and beginners, as it comes in a pre-charged syringe for easy applications.

Combined with algae and fungi compounds, the gel contains substances with hemostatic agents and is designed to act quickly, helping to reduce the risk of blood loss.

Since effectively prevents serious bloodshed, TraumaGelli may be necessary in emergency situations, potentially saving his life by controlling his blood loss until advanced medical care is provided.

The company that created the gelin has declared they have enjoyed approval of the FDA since TraumaGel is a monument achievement and brings another step forward in their goal of saving lives and transforming the standard of emergency care.

Our hemostattic technology vest is much more advanced than all the hemostatic gels that have been made so far”, says the company's statement.
Besides being used for the military, the substance will be available to government health agencies, medical professionals and emergency services.
TraumaGel from Cresylon is expected to be launched on the United States market at the end of 2024.